Versiti - Versiti Launches New Test to Improve HIT Diagnostics | Video Gallery | Versiti

Versiti Launches New Test to Improve HIT Diagnostics

Versiti Launches New Test to Improve HIT Diagnostics


Versiti is excited to announce the launch of its new P-Selectin Expression Assay (PEA). The PEA was developed as the next evolution diagnostic option for patients suspected to have Heparin-Induced Thrombocytopenia (HIT) 

 
About Blood Donation
Donate blood, donate plasma or donate platelets at a blood donation center near you or a blood drive near you. Make an appointment to donate blood today.
 
Funding Research
Versiti Blood Research Institute Foundation accepts financial and philanthropic gifts from donors, which helps to propel lifesaving research.
 
Share Your Story
Versiti invites you to share your story and photo to help encourage more people to give back. You may even be featured throughout the year on our social media.
 
Versiti Blood Research Institute
Versiti Blood Research Institute investigators study blood disorders like hemophilia, blood cancers like leukemia, and other blood diseases.